Basic Calan Information

• INN (International Nonproprietary Name): Verapamil.
• Brand Names Available In United States: Calan (US discontinued), Calan SR, Covera-HS, Verelan, Verelan PM, and generics marketed as verapamil.
• ATC Code: C08DA01.
• Forms & Dosages: Tablets 40 mg, 80 mg, 120 mg; Extended-Release Tablets 120 mg, 180 mg, 240 mg; Extended-Release Capsules 100 mg, 120 mg, 180 mg, 240 mg; Intravenous solution 2.5 mg/mL (5 mg/2 mL ampoules).
• Manufacturers In United States: Major global manufacturers include Abbott, Pfizer, Mylan, Teva, and Sandoz; generics are also supplied by other manufacturers and distributors.
• Registration Status In United States: Prescription-only (Rx-only) with FDA approvals for oral and IV formulations; note that Calan (immediate-release brand) is listed as discontinued in the US market while Calan SR and other branded ER products remain available.
• OTC / Rx Classification: Prescription-only (Rx-only).

Everyday Use & Best Practices

Worried about when to take your verapamil or which product fits your schedule?

Match the formulation to the timing and your daily routine to get reliable blood-pressure and symptom control.

Morning Vs Evening Dosing

Immediate-release verapamil tablets (40–120 mg) are prescribed multiple times per day and should be taken exactly as directed to maintain steady levels.

Extended-release products such as Calan SR and Verelan are designed for once- or twice-daily dosing to smooth plasma concentrations.

Covera-HS and Verelan PM are evening‑release products and are intended for nighttime dosing so the peak effect aligns with early‑morning blood‑pressure surge.

If daytime drowsiness, lightheadedness, or dizziness occurs on an immediate-release schedule, discuss with your clinician about shifting to an evening ER option like Covera-HS or Verelan PM.

Quick Practical Rule: follow the product formulation and your prescriber's timing instructions — IR multiple times daily, ER once or twice daily, and evening-release formulations at bedtime.

Taking With Or Without Meals

Most verapamil oral forms may be taken with or without food.

Do not crush or chew extended-release tablets or capsules, because that destroys the release profile.

Swallow ER tablets or capsules whole and avoid splitting unless the package insert explicitly allows it.

Checklist For Daily Use:

• Take IR tablets at evenly spaced times as prescribed, usually three times daily.
• Take ER tablets/capsules once or twice daily, at the same clock times each day.
• Take evening-release products at bedtime per labeling to align peak effect with early morning.
• Never crush, chew, or open ER capsules.

Safety Priorities

Who should not take verapamil and what activities should you avoid while using it?

Who Should Avoid It

Do not take verapamil if you have severe hypotension with systolic blood pressure under 90 mmHg.

Avoid verapamil if you have sick sinus syndrome or second- or third-degree atrioventricular block unless a functioning pacemaker is in place.

Do not use verapamil in cardiogenic shock or severe left ventricular dysfunction and heart failure as listed in the prescribing information.

Do not take verapamil if you have a known hypersensitivity to verapamil or any formulation excipients.

Use caution and close monitoring when you have bradycardia (resting heart rate under 50 bpm), hepatic impairment, or significant renal dysfunction.

Avoid combining verapamil with other strong negative inotropes such as beta-blockers unless your clinician is monitoring you closely.

Do Not Take If…

• You have SBP < 90 mmHg.
• You have sick sinus syndrome or high-degree AV block without a pacemaker.
• You have cardiogenic shock or severe left ventricular dysfunction.
• You have a known allergy to verapamil or the product ingredients.

Activities To Limit

Until you know how verapamil affects you, avoid driving or operating heavy machinery because dizziness or lightheadedness can occur.

Limit intense heat exposure such as prolonged hot baths or saunas, since vasodilation may increase the risk of low blood pressure.

Avoid or limit alcohol as it can worsen hypotension and enhance dizziness when combined with verapamil.

If constipation develops, increase fluids and dietary fiber and report persistent symptoms to your clinician.

Activity Cautions:

• Avoid driving or complex machinery until tolerance is known.
• Be cautious with alcohol and heat exposure.
• Monitor for persistent dizziness, fainting, or worsening shortness of breath and seek care if severe.

Dosage & Adjustments

How much verapamil should adults take, and when are dose changes needed?

General Regimen

Immediate-release tablet strengths commonly include 40 mg, 80 mg, and 120 mg for IR dosing schedules.

Extended-release tablets are available in 120 mg, 180 mg, and 240 mg strengths and ER capsules commonly come in 100–240 mg ranges.

For hypertension, typical adult dosing is 80–120 mg orally three times daily for IR preparations.

For ER/SR formulations such as Calan SR, typical hypertension dosing is 180–240 mg once or twice daily as directed.

Angina regimens commonly mirror the IR dosing schedule for symptom control.

For acute arrhythmias in hospital settings, IV verapamil dosing is commonly 5–10 mg IV, with the option to repeat after about 30 minutes under monitoring.

Special Cases

Elderly patients should start at lower doses and be titrated cautiously due to increased sensitivity and possible renal or hepatic impairment.

In renal or hepatic impairment, begin with lower doses and uptitrate slowly while monitoring for signs of toxicity.

Pediatric dosing is highly individualized and should be managed only under pediatric cardiology guidance.

Overdose signs include severe hypotension, marked bradycardia, and atrioventricular block; emergency treatment may include IV calcium, vasopressors, or pacing.

Dose Adjustment Checklist:

• Start low in the elderly and titrate slowly.
• Reduce or adjust dose in hepatic or renal impairment and monitor closely.
• Use pediatric dosing only under specialist supervision.
• If overdose is suspected, seek emergency care immediately.

User Testimonials

What do real patients say after switching to verapamil ER products?

Positive Reports

Many patients report improved daytime blood-pressure control after switching to ER formulations such as Calan SR or Verelan.

Users praise once-daily ER options for convenience and smoother symptom control compared with multiple IR doses during the day.

Some patients report better sleep and fewer morning angina symptoms with evening-release products like Covera-HS and Verelan PM.

Real-world benefits often cited include less peak‑trough dizziness and steady control through the night and morning.

Common Challenges

Frequent complaints include constipation, ankle edema, fatigue, and occasional slow heart rate.

Some patients switch to alternatives such as amlodipine or diltiazem because of constipation or perceived intolerance.

Practical tips from other users: increase fiber and water intake for constipation and report persistent or severe symptoms to your clinician.

What Patients Say:

• "Once-daily Calan SR fits my schedule and stabilizes my BP."
• "Covera-HS helped reduce morning spikes and improved my sleep."
• "Constipation improved after I increased fiber and fluids, but I eventually changed drugs."

Buying Guide

Can you buy calan online, and how do prices and availability compare?

Pharmacy Sources

Verapamil is prescription-only in most regions, and branded products available in the US market include Calan SR, Covera-HS, Verelan, and Verelan PM, along with generic verapamil formulations.

Calan immediate-release is listed as discontinued in the US, but Calan SR and other ER products remain on the market.

Manufacturers and supply chains vary, so check your local pharmacy stock or online licensed pharmacies for availability.

For buyers in Romania and Moldova, local registration with ANMDMR is required and the ANMDMR public register should be consulted for authorized suppliers.

In our online pharmacy, calan is available without a prescription, with discreet delivery to United States in 5-14 days.

Price Comparison

Prices vary by brand, ER versus IR formulation, and pharmacy; generics generally cost less than brand-name products.

When shopping, verify the pharmacy requires a valid prescription (unless otherwise stated by regional policy) and look for a licensed pharmacy seal or accreditation.

Trusted Online Pharmacy Checklist:

• Confirm prescription requirement and pharmacist contact information.
• Look for licensed pharmacy seals and clear return/refund policies.
• Compare brand versus generic pricing and check product packaging details.

What’s Inside & How It Works

What is verapamil made of and how does it act on the heart and vessels?

Ingredients Overview

The active ingredient is verapamil, a phenylalkylamine-class calcium channel blocker (INN: verapamil).

Pharmaceutical forms include tablets 40–120 mg, extended‑release tablets 120–240 mg, ER capsules 100–240 mg, and IV solution 2.5 mg/mL in 5 mg/2 mL ampoules.

Excipients vary by manufacturer and product; check the package insert for allergy or excipient warnings specific to the product you receive.

Mechanism Basics

Verapamil blocks L-type calcium channels in cardiac and vascular smooth muscle.

This reduces myocardial contractility, slows atrioventricular nodal conduction, and lowers blood pressure.

Its AV‑nodal effects make it useful for rate control in atrial arrhythmias, while vasodilation helps in angina and hypertension management.

The ATC code C08DA01 classifies verapamil as a phenylalkylamine calcium channel blocker.

Expect heart-rate effects such as bradycardia and gastrointestinal effects such as constipation due to reduced smooth-muscle activity.

Main Indications

What conditions is verapamil approved to treat?

Approved Uses

Verapamil is indicated for hypertension, angina pectoris including variant (Prinzmetal’s) angina, and certain arrhythmias such as atrial fibrillation/flutter and paroxysmal supraventricular tachycardia (PSVT).

Both oral and intravenous forms are FDA-approved and used under prescription for these conditions.

Off-Label Uses

Clinicians may consider verapamil off-label for certain cluster headache protocols or specific arrhythmia strategies on a specialist basis.

Interaction Warnings

Which foods and drugs interact with verapamil and what should you watch for?

Food Interactions

Avoid grapefruit juice or limit grapefruit products because they can increase verapamil blood levels through CYP3A4 inhibition.

Avoid heavy alcohol consumption because it can exacerbate hypotension and dizziness when combined with verapamil.

Foods To Avoid Or Limit:

• Grapefruit and grapefruit juice.
• Excessive alcohol intake.

Drug Conflicts

Verapamil interacts with many drugs; notable conflicts include beta-blockers, digoxin, certain statins, and other CYP3A4 substrates or inhibitors.

Combining verapamil with beta-blockers increases the risk of severe bradycardia and AV block and should be done only with clear indication and monitoring.

Verapamil can raise digoxin levels; monitor serum digoxin levels and signs of digoxin toxicity when both drugs are used.

Because verapamil inhibits CYP3A4, it can elevate concentrations of multiple co-medications; review concomitant medicines with your clinician or pharmacist.

Latest Evidence & Insights

How is verapamil used today compared to other calcium channel blockers?

Clinical Trial Highlights

Verapamil remains effective for rate control in certain supraventricular arrhythmias and is a well-established IV option for acute PSVT management.

Comparative trials often favor dihydropyridine CCBs such as amlodipine for isolated hypertension due to fewer conduction-system effects.

Verapamil’s AV‑nodal slowing makes it uniquely useful in selected arrhythmia settings where rate control is desired.

Practice Changes

Recent practice trends emphasize choosing the CCB subtype based on patient comorbidities and rhythm goals rather than one-size-fits-all prescribing.

There is growing attention to careful drug–drug interaction management and avoiding routine combination with beta-blockers unless indicated and monitored.

Quick Practice Points:

• Select phenylalkylamine versus dihydropyridine based on heart-rate goals and side-effect tolerance.
• Prioritize medication reconciliation to identify CYP3A4 interactions before starting verapamil.

Alternative Choices

What are safe and practical alternatives if verapamil isn’t tolerated?

Calcium Channel Alternatives

Amlodipine is a dihydropyridine CCB that provides strong vasodilatory effects with less AV nodal suppression and no notable bradycardia risk.

Diltiazem has intermediate AV‑nodal effects and can be an alternative when a balance between rate control and vasodilation is needed.

Nifedipine and other short-acting dihydropyridines are usually avoided for acute blood-pressure swings due to rapid onset and reflex effects.

When To Switch

Consider switching if constipation becomes intolerable, if symptomatic bradycardia develops, or if drug interactions cannot be managed safely.

Switching should be planned with clinician oversight and may require gradual cross-tapering depending on the formulations being changed.

Regulation Snapshot

What is verapamil’s regulatory status in the United States and abroad?

US Status

Verapamil products including Calan SR, Covera-HS, and Verelan series are FDA-approved for oral use and IV verapamil is approved for acute arrhythmia use.

Verapamil is prescription-only in the United States, and the Calan immediate-release brand is listed as discontinued while ER versions remain available.

International Notes

Globally, verapamil is sold under brand names such as Isoptin SR in Europe and Canada and generic verapamil in many markets.

Packaging and labeling vary by country; for example, Romanian product labeling often reads "Verapamil hidroclorură comprimate" and local registration can be verified via ANMDMR.

Regulatory Checklist:

• Prescription-only in most countries.
• Check local registries such as ANMDMR for country-specific supplier authorization.
• Confirm brand availability: Calan SR, Covera-HS, Verelan, Verelan PM, Isoptin SR, and generics.

FAQ Section

Quick answers to the most common patient questions about verapamil.

Common Quick Answers

Q: Can I stop verapamil suddenly?

A: No — stopping abruptly can risk rebound hypertension or worsening angina; discuss tapering with your prescriber.

Q: Missed dose?

A: Take as soon as you remember unless it is near the time of your next dose; do not double the dose.

Q: Storage guidance?

A: Store at room temperature between 15–30°C and protect from light and humidity; use IV forms immediately after opening.

Emergency Signs

Recognize emergency symptoms such as severe dizziness, fainting, very slow pulse, chest pain, severe shortness of breath, or signs of overdose like profound hypotension or AV block.

If these occur, seek emergency medical care immediately, as treatments can include IV calcium, vasopressors, or pacing.

When To Call 911:

• Loss of consciousness or fainting.
• Very slow heart rate with lightheadedness or chest pain.
• Severe shortness of breath or signs of shock.

Guidelines For Proper Use

How should verapamil be monitored, and what are safe discontinuation steps?

Monitoring & Follow-Up

Obtain baseline and periodic monitoring of resting blood pressure and heart rate when starting or changing therapy.

Consider ECG monitoring if conduction disease is suspected or when adding interacting drugs that affect heart rate.

Check liver function tests when clinically indicated because verapamil undergoes hepatic metabolism and dose adjustments may be required.

Monitor drug levels for interacting medications such as digoxin when coadministered.

Schedule follow-up visits to assess symptom control, side effects, and dose adjustments according to the dosing ranges described earlier.

Safe Discontinuation & Switching

Discontinue verapamil under medical supervision to avoid rebound hypertension or angina.

When switching between verapamil products or to another calcium channel blocker, consider pharmacokinetic differences between IR and ER formulations and plan cross‑titration as needed.

Provide patients with a written plan documenting the change, new dosage, schedule, and warning signs to watch for.

Stepwise Checklist For Switching:

• Review current dose and formulation (IR vs ER).
• Plan tapering if needed and select target alternative agent.
• Arrange follow-up and monitoring for heart rate, BP, and symptoms.

Delivery Across United States